154 related articles for article (PubMed ID: 2842130)
1. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
Meier R; Gyr K
Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
[TBL] [Abstract][Full Text] [Related]
2. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
[TBL] [Abstract][Full Text] [Related]
3. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
[TBL] [Abstract][Full Text] [Related]
4. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
[TBL] [Abstract][Full Text] [Related]
5. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
[TBL] [Abstract][Full Text] [Related]
6. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
[TBL] [Abstract][Full Text] [Related]
7. Improvement of hepatic encephalopathy treated with flumazenil.
Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
[TBL] [Abstract][Full Text] [Related]
8. [Current possibilities in the therapy of hepatic encephalopathy].
Meier PJ; Bansky G
Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hepatic encephalopathy with flumazenil].
Elkjaer JM; Jensen TU; Emborg J
Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
[TBL] [Abstract][Full Text] [Related]
10. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
Ferenci P; Grimm G
Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Encephalopathy.
Blei AT; Córdoba J;
Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
[TBL] [Abstract][Full Text] [Related]
12. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
Ferenci P; Grimm G
Adv Exp Med Biol; 1990; 272():255-65. PubMed ID: 2103692
[TBL] [Abstract][Full Text] [Related]
14. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
Zeng Z; Li YY
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
[TBL] [Abstract][Full Text] [Related]
15. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
16. Flumazenil: a benzodiazepine antagonist.
Hoffman EJ; Warren EW
Clin Pharm; 1993 Sep; 12(9):641-56; quiz 699-701. PubMed ID: 8306565
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy.
Basile AS; Harrison PM; Hughes RD; Gu ZQ; Pannell L; McKinney A; Jones EA; Williams R
Hepatology; 1994 Jan; 19(1):112-21. PubMed ID: 8276347
[TBL] [Abstract][Full Text] [Related]
18. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
[TBL] [Abstract][Full Text] [Related]
19. [Specific therapy of acute benzodiazepine poisoning using flumazenil (Ro 15-1788)].
Hruby K; Prischl F; Smetana R; Pernecker M; Donner A; Scholtz I; Grimm G
Wien Med Wochenschr; 1987 May; 137(9):179-83. PubMed ID: 2885978
[TBL] [Abstract][Full Text] [Related]
20. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy.
Macdonald GA; Frey KA; Agranoff BW; Minoshima S; Koeppe RA; Kuhl DE; Shulkin BL; Lucey MR
Hepatology; 1997 Aug; 26(2):277-82. PubMed ID: 9252134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
